Human muscle precursor cell regeneration in the mouse host is enhanced by growth factors

被引:15
作者
Brimah, K
Ehrhardt, J
Mouly, V
Butler-Browne, GS
Partridge, TA
Morgan, JE
机构
[1] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Muscle Cell Biol Grp, London W12 0NN, England
[2] Univ Paris 06, UMR 7000, F-75634 Paris 13, France
[3] CNRS, F-75634 Paris 13, France
关键词
D O I
10.1089/1043034042431155
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 0836 [生物工程]; 090102 [作物遗传育种]; 100705 [微生物与生化药学];
摘要
The aim of this study was to optimize human muscle formation in vivo from implanted human muscle precursor cells. We transplanted donor muscle precursor cells (MPCs) prepared from postnatal or fetal human muscle into immunodeficient host mice and showed that irradiation of host muscle significantly enhanced muscle formation by donor cells. The amount of donor muscle formed in cryodamaged host muscle was increased by exposure of donor cells to growth factors before their implantation into injured host muscle. Insulin-like growth factor type I (IGF-I) significantly increased the amount of muscle formed by postnatal human muscle cells, but not by fetal human MPCs. However, treatment of fetal muscle cells with IGF-I, in combination with basic fibroblast growth factor and plasmin, significantly increased the amount of donor muscle formed. In vivo, human MPCs formed mosaic human-mouse muscle fibers, in which each human myonucleus was associated with a zone of human sarcolemmal protein spectrin.
引用
收藏
页码:1109 / 1124
页数:16
相关论文
共 105 条
[81]
LIMITED DIFFUSIBILITY OF GENE-PRODUCTS DIRECTED BY A SINGLE NUCLEUS IN THE CYTOPLASM OF MULTINUCLEATED MYOFIBERS [J].
ONO, T ;
ONO, K ;
MIZUKAWA, K ;
OHTA, T ;
TSUCHIYA, T ;
TSUDA, M .
FEBS LETTERS, 1994, 337 (01) :18-22
[82]
A novel means of drug delivery: Myoblast-mediated gene therapy and regulatable retroviral vectors [J].
Ozawa, CR ;
Springer, ML ;
Blau, HM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :295-317
[83]
Partridge T, 2000, NEUROL SCI, V21, pS939
[84]
Stem cell route to neuromuscular therapies [J].
Partridge, TA .
MUSCLE & NERVE, 2003, 27 (02) :133-141
[85]
CONVERSION OF MDX MYOFIBERS FROM DYSTROPHIN-NEGATIVE TO DYSTROPHIN-POSITIVE BY INJECTION OF NORMAL MYOBLASTS [J].
PARTRIDGE, TA ;
MORGAN, JE ;
COULTON, GR ;
HOFFMAN, EP ;
KUNKEL, LM .
NATURE, 1989, 337 (6203) :176-179
[86]
Identification of the RAG-1 as a suitable mouse model for mitochondrial DNA disease [J].
Pye, D ;
Watt, DJ ;
Walker, C ;
Lightowlers, RN ;
Turnbull, DM .
NEUROMUSCULAR DISORDERS, 2004, 14 (05) :329-336
[87]
TRANSFER OF A PROTEIN ENCODED BY A SINGLE NUCLEUS TO NEARBY NUCLEI IN MULTINUCLEATED MYOTUBES [J].
RALSTON, E ;
HALL, ZW .
SCIENCE, 1989, 244 (4908) :1066-1069
[88]
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways [J].
Rommel, C ;
Bodine, SC ;
Clarke, BA ;
Rossman, R ;
Nunez, L ;
Stitt, TN ;
Yancopoulos, GD ;
Glass, DJ .
NATURE CELL BIOLOGY, 2001, 3 (11) :1009-1013
[89]
ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773
[90]
Transforming growth factor-β inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway [J].
Rousse, S ;
Lallemand, F ;
Montarras, D ;
Pinset, C ;
Mazars, A ;
Prunier, C ;
Atfi, A ;
Dubois, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :46961-46967